Momentkid Prima Infanzia (Ibuprofen)

Ibuprofen, the active ingredient in Momentkid Prima Infanzia, is a nonsteroidal anti-inflammatory drug presented as a rectal formulation for rectal use. It is employed to relieve mild to moderate pain, lower fever, and mitigate inflammatory discomfort in children, offering a convenient alternative when oral administration is not feasible.

GNH USA supplies Momentkid Prima Infanzia as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, with the product sourced from the European Union market and meeting applicable quality standards.

Ibuprofen acts systemically to alleviate symptoms associated with inflammatory and febrile conditions in children.

- Pain: Provides relief from mild to moderate acute pain such as headache, toothache, or postoperative discomfort. - Fever: Reduces elevated body temperature associated with viral or bacterial infections. - Inflammation: Decreases swelling and discomfort in minor musculoskeletal injuries or soft‑tissue inflammation.

Ibuprofen may be associated with a range of adverse reactions, varying from mild to severe.

Common Side Effects: - Gastrointestinal discomfort: nausea, dyspepsia, or abdominal pain. - Headache: mild to moderate intensity. - Dizziness or vertigo. - Skin reactions: mild rash or itching. - Local irritation: rectal burning or discharge.

Serious or Rare Side Effects: - Gastrointestinal bleeding or ulcer perforation. - Acute renal impairment or failure. - Anaphylactic or severe allergic reactions. - Stevens‑Johnson syndrome or toxic epidermal necrolysis. - Hepatotoxicity or severe liver injury.

When using ibuprofen rectal suppositories, certain precautions should be observed to ensure safe and effective therapy.

- Age and weight: Use only in children for whom the prescriber has determined an appropriate dose based on age and body weight. - Hypersensitivity: Avoid if the patient has known allergy to ibuprofen or other NSAIDs. - Gastrointestinal risk: Caution in children with a history of peptic ulcer disease or gastrointestinal bleeding. - Renal function: Monitor renal status in patients with dehydration, renal impairment, or concurrent nephrotoxic drugs. - Concomitant medications: Use carefully with anticoagulants, corticosteroids, or other NSAIDs to reduce bleeding risk. - Store below 25°C: Keep in the original packaging, protect from moisture and heat.

Ibuprofen can interact with several medicines, altering its efficacy or safety profile.

Major Interactions (Avoid): - Anticoagulants (e.g., warfarin): increased risk of serious bleeding. - Other NSAIDs or aspirin: heightened gastrointestinal toxicity. - Corticosteroids: additive risk of ulceration and bleeding.

Moderate Interactions (Monitor Closely): - ACE inhibitors or ARBs: may reduce renal function, especially in volume‑depleted patients. - Diuretics: potential for decreased antihypertensive effect and renal impairment. - Lithium: ibuprofen can raise lithium serum concentrations. - Methotrexate: reduced clearance leading to toxicity. - Selective serotonin reuptake inhibitors (SSRIs): increased bleeding tendency.